Jens Hoffmann , Ph.D.
Education and Research Experience
1989 Diploma in Pharmacy, Experimental Pharmacology and Toxicology
1989 - 1990 Central Institute for Cancer Research Berlin Clinical Pharmacology
1991- 1994 German Cancer Research Ph. D. Student
Centre Heidelberg and Experimental Oncology
Molecular Medicine Berlin
1995 Schering AG Berlin Postdoctoral Training
1996 University of Pittsburgh Postdoctoral Training
School of Medicine
Department of Pharmacology
1997 - 2009 Schering AG Berlin Group leader in Oncology Research
Bayer Pharma AG
2009 - EPO-Berlin Buch GmbH CEO
CRO services in preclinical oncology and translational research.
Dr. Hoffmann has special expertise for pharmacological investigations concerning endocrine tumors. Biomarker and translational research is another focus of his scientific work. He has published more than 50 original articles in peer reviewed journals and filed more than 30 patents. Dr. Hoffmann is member of the German Cancer Foundation and the Board of the Experimental Cancer Research Division (AEK) and the American Association for Cancer Research (AACR).